153475063Open: Role of a CCK receptor antagonist proglumide in management of chronic pancreatitisNCT05551858NationalAdultTreatmentProglumide 1200 mg / day in Part 1 and Proglumide versus placebo in Part 2IIOtherClinically established chronic pancreatitis and radiographic evidenceRandomized placebo controlled pseudo crossover trialSmith, JillGeorgetown University Medical Center : Wenqiang Chen; Lombardi Comprehensive Cancer Center : Wenqiang ChenAges 18-75- 14646Wenqiang ChenWenqiang Chenwc594@georgetown.edu
2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>